AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma

Fukuda et al. demonstrate that AIM2 expression in DCs within human melanoma is a poor prognostic sign and that AIM2-deficient DC vaccination enhances melanoma immunotherapeutic responses by promoting STING-induced IFN secretion as well as limiting IL-1β and IL-18 production.

[1]  E. Kleinerman,et al.  Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103+ conventional dendritic cells , 2020, Journal for ImmunoTherapy of Cancer.

[2]  H. Widlund,et al.  IL1α Antagonizes IL1β and Promotes Adaptive Immune Rejection of Malignant Tumors , 2020, Cancer Immunology Research.

[3]  Michele De Palma,et al.  Engineering dendritic cell vaccines to improve cancer immunotherapy , 2019, Nature Communications.

[4]  S. Han,et al.  Human CD141+ dendritic cells generated from adult peripheral blood monocytes. , 2019, Cytotherapy.

[5]  I. Melero,et al.  Dendritic cells in cancer immunology and immunotherapy , 2019, Nature Reviews Immunology.

[6]  R. Germain,et al.  Host conditioning with IL-1β improves the antitumor function of adoptively transferred T cells , 2019, The Journal of experimental medicine.

[7]  J. Larkin,et al.  Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study. , 2019, The Lancet. Oncology.

[8]  I. Melero,et al.  Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen , 2019, Journal of Immunotherapy for Cancer.

[9]  R. Weichselbaum,et al.  Non‐canonical NF‐&kgr;B Antagonizes STING Sensor‐Mediated DNA Sensing in Radiotherapy , 2018, Immunity.

[10]  G. Shrivastava,et al.  Gasdermin D Restrains Type I Interferon Response to Cytosolic DNA by Disrupting Ionic Homeostasis , 2018, Immunity.

[11]  Kit-San Yuen,et al.  Inhibition of AIM2 inflammasome activation by a novel transcript isoform of IFI16 , 2018, EMBO reports.

[12]  Li Wang,et al.  Dendritic cell trafficking in tumor-bearing mice , 2018, Cancer Immunology, Immunotherapy.

[13]  M. Moore,et al.  Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo , 2018, Nucleic acids research.

[14]  G. Kaplanski.  Interleukin‐18: Biological properties and role in disease pathogenesis , 2017, Immunological reviews.

[15]  Lisa E. Wagar,et al.  High‐Dimensional Phenotypic Mapping of Human Dendritic Cells Reveals Interindividual Variation and Tissue Specialization , 2017, Immunity.

[16]  Jonathan L. Schmid-Burgk,et al.  The DNA Inflammasome in Human Myeloid Cells Is Initiated by a STING-Cell Death Program Upstream of NLRP3 , 2017, Cell.

[17]  R. Flavell,et al.  The DNA Methylcytosine Dioxygenase Tet2 Sustains Immunosuppressive Function of Tumor‐Infiltrating Myeloid Cells to Promote Melanoma Progression , 2017, Immunity.

[18]  J. Luban,et al.  Intron-containing RNA from the HIV-1 provirus activates type I interferon and inflammatory cytokines , 2017, Nature Communications.

[19]  P. Agostinis,et al.  Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape. , 2017, Trends in immunology.

[20]  T. Gajewski,et al.  Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy. , 2017, Cancer cell.

[21]  N. Hacohen,et al.  Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors , 2017, Science.

[22]  M. Shi,et al.  Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways , 2017, International journal of molecular sciences.

[23]  P. Mozetic,et al.  Combining Type I Interferons and 5-Aza-2'-Deoxycitidine to Improve Anti-Tumor Response against Melanoma. , 2017, The Journal of investigative dermatology.

[24]  T. Gajewski,et al.  Innate immune signaling and regulation in cancer immunotherapy , 2016, Cell Research.

[25]  S. Steinberg,et al.  Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  T. Graeber,et al.  Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T Cells , 2016, Cancer Immunology Research.

[27]  A. Bowie,et al.  The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons. , 2016, Immunity.

[28]  Jason B. Williams,et al.  Antagonism of the STING Pathway via Activation of the AIM2 Inflammasome by Intracellular DNA , 2016, The Journal of Immunology.

[29]  Si Ming Man,et al.  AIM2 inflammasome in infection, cancer, and autoimmunity: Role in DNA sensing, inflammation, and innate immunity , 2016, European journal of immunology.

[30]  H. Okamura,et al.  Augmentation of Immune Checkpoint Cancer Immunotherapy with IL18 , 2016, Clinical Cancer Research.

[31]  Masa Bosnjak,et al.  Cytosolic DNA Sensor Upregulation Accompanies DNA Electrotransfer in B16.F10 Melanoma Cells. , 2016, Molecular therapy. Nucleic acids.

[32]  V. Hornung,et al.  Suppression of intratumoral CCL22 by type i interferon inhibits migration of regulatory T cells and blocks cancer progression. , 2015, Cancer research.

[33]  P. Chakravarty,et al.  GM-CSF Mouse Bone Marrow Cultures Comprise a Heterogeneous Population of CD11c(+)MHCII(+) Macrophages and Dendritic Cells. , 2015, Immunity.

[34]  S. Aiba,et al.  Immunomodulatory effect of peritumorally administered interferon-beta on melanoma through tumor-associated macrophages , 2015, Oncoimmunology.

[35]  S. Ferrini,et al.  Context‐dependent role of IL‐18 in cancer biology and counter‐regulation by IL‐18BP , 2015, Journal of leukocyte biology.

[36]  D. Cho,et al.  IL-18 Enhances Immunosuppressive Responses by Promoting Differentiation into Monocytic Myeloid-Derived Suppressor Cells , 2014, The Journal of Immunology.

[37]  Ying Wang,et al.  STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. , 2014, Immunity.

[38]  R. Weichselbaum,et al.  STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors. , 2014, Immunity.

[39]  M. Merad,et al.  Selective and efficient generation of functional Batf3-dependent CD103+ dendritic cells from mouse bone marrow. , 2014, Blood.

[40]  R. Emerson,et al.  PD-1 blockade induces responses by inhibiting adaptive immune resistance , 2014, Nature.

[41]  Z. Berneman,et al.  Clinical use of dendritic cells for cancer therapy. , 2014, The Lancet. Oncology.

[42]  D. Campbell,et al.  Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection , 2014, The Journal of experimental medicine.

[43]  L. French,et al.  Metastatic melanoma cell lines do not secrete IL-1β but promote IL-1β production from macrophages. , 2014, Journal of dermatological science.

[44]  C. Hunter,et al.  CXCL10 Is Critical for the Progression and Maintenance of Depigmentation in a Mouse Model of Vitiligo , 2014, Science Translational Medicine.

[45]  Janet M. Young,et al.  Extensive evolutionary and functional diversity among mammalian AIM2-like receptors , 2012, The Journal of experimental medicine.

[46]  S. Reuter,et al.  DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection. , 2012, The Journal of clinical investigation.

[47]  G. Lizée,et al.  Constitutive Aberrant Endogenous Interleukin-1 Facilitates Inflammation and Growth in Human Melanoma , 2011, Molecular Cancer Research.

[48]  G. Doria,et al.  APC Activation by IFN-α Decreases Regulatory T Cell and Enhances Th Cell Functions , 2010, The Journal of Immunology.

[49]  V. Dixit,et al.  Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis , 2010, Proceedings of the National Academy of Sciences.

[50]  Eva Szomolanyi-Tsuda,et al.  The AIM2 inflammasome is essential for host-defense against cytosolic bacteria and DNA viruses , 2010, Nature Immunology.

[51]  V. Hornung,et al.  RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III–transcribed RNA intermediate , 2009, Nature Immunology.

[52]  M. Neller,et al.  Antigens for cancer immunotherapy. , 2008, Seminars in immunology.

[53]  G. Barber,et al.  STING an Endoplasmic Reticulum Adaptor that Facilitates Innate Immune Signaling , 2008, Nature.

[54]  E. Shevach,et al.  Costimulatory effects of IL‐1 on the expansion/differentiation of CD4+CD25+Foxp3+ and CD4+CD25+Foxp3– T cells , 2008, Journal of leukocyte biology.

[55]  Franca Ronchese,et al.  Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[56]  P. Hwu,et al.  Dendritic Cells Strongly Boost the Antitumor Activity of Adoptively Transferred T Cells In vivo , 2004, Cancer Research.

[57]  V. Engelhard,et al.  Route of Immunization with Peptide-pulsed Dendritic Cells Controls the Distribution of Memory and Effector T Cells in Lymphoid Tissues and Determines the Pattern of Regional Tumor Control , 2003, The Journal of experimental medicine.

[58]  Masatoshi Suzuki,et al.  Production of Mice Deficient in Genes for Interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 Receptor Antagonist Shows that IL-1β Is Crucial in Turpentine-induced Fever Development and Glucocorticoid Secretion , 1998, The Journal of experimental medicine.

[59]  Yan A. Su,et al.  Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma , 1997, Oncogene.